Biolife Solutions (BLFS) Cost of Revenue (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cost of Revenue data on file, last reported at $2.5 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $2.5 million, up 3.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.0 million (up 38.21% YoY), and the FY2025 annual result was $34.1 million, up 38.88% from the prior year.
• Cost of Revenue retreated to $2.5 million in Q1 2026 per BLFS's latest filing, from $26.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $26.2 million in Q4 2025 and troughed at -$3.9 million in Q4 2022.
• A 5-year average of $6.0 million and a median of $3.8 million in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue tumbled 182.23% in 2022, then jumped 455.48% in 2023.
• A 5-year view of Cost of Revenue shows it stood at -$3.9 million in 2022, then jumped by 455.48% to $14.0 million in 2023, then climbed by 23.04% to $17.2 million in 2024, then jumped by 52.69% to $26.2 million in 2025, then slumped by 90.37% to $2.5 million in 2026.
• Business Quant data shows BLFS's Cost of Revenue at $2.5 million in Q1 2026, $26.2 million in Q4 2025, and $2.5 million in Q3 2025.